Delivery Order SPE2DB22D3301-SPE2DB25FX4LZ
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,014.48, is a delivery order under an Indefinite Delivery Contract (IDC) for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price arrangement. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,652.50 delivery order contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 50ML, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of June 14, 2024. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has a completion date of June 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.50 firm fixed-price contract is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a medical product used in healthcare settings. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,071.52 and an Ultimate Completion Date of June 16, 2025. The contract is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 150ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,667.68 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML Infusion Bottles, with a period of performance through May 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which covers a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The award, valued at $3,498.20, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a specialty pharmaceutical product, to DLA Troop Support Medical facilities that support the Department of Defense. The contract is a firm fixed price delivery order with a completion date of March 19, 2024. It is not associated with a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the U.S. Department of Defense (DoD) Medical Supply Chain for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The $6,867.92 delivery order contract is a firm fixed-price arrangement without any set-aside designation. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to...